Dennis Charney
Director/Board Member chez AMDeC Foundation, Inc.
Profil
Dennis S.
Charney is currently the Director of AMDeC Foundation, Inc., New York Genome Center, Mount Sinai Genomics, Inc., and CastleVax, Inc. He is also the Dean of Icahn School of Medicine at Mount Sinai since 2004 and the President-Academic Affairs of The Mount Sinai Health System, Inc. since 2013.
Previously, he was the Chairman-Scientific Counselors Board at the National Institute of Mental Health.
He also served as a Professor at Yale University from 1990 to 2000.
Charney received his undergraduate degree from Rutgers State University of New Jersey and his doctorate from Pennsylvania State University College of Medicine.
He was an Independent Director at GeneDx Holdings Corp.
from 2021 to 2023.
Postes actifs de Dennis Charney
| Sociétés | Poste | Début |
|---|---|---|
| AMDeC Foundation, Inc. | Director/Board Member | - |
New York Genome Center
 New York Genome Center Miscellaneous Commercial ServicesCommercial Services New York Genome Center operates as an independent, nonprofit academic research institution that provides genomic research. It provides research on neurodegenerative disease, neuropsychiatric disease, and cancer. The company was founded in 2011 and is headquartered in New York, NY. | Director/Board Member | - |
Mount Sinai Genomics, Inc.
 Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT. | Director/Board Member | - |
The Mount Sinai Health System, Inc.
 The Mount Sinai Health System, Inc. Medical/Nursing ServicesHealth Services The Mount Sinai Health System, Inc. provides health care system services. It is an integrated health care system providing exceptional medical care to our local and global communities. The company is headquartered in New York, NY. | Corporate Officer/Principal | 01/09/2013 |
| Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | 01/01/2004 |
CastleVax, Inc.
 CastleVax, Inc. BiotechnologyHealth Technology CastleVax, Inc. is an American vaccine platform company based on technology developed at the Icahn School of Medicine at Mount Sinai, headquartered in an undisclosed location. The private company's platform uses a disease virus to induce the human immune system to produce neutralizing antibodies targeted at a range of emerging and pandemic viruses, including SARS-CoV-2. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax's leading candidate, NDV-HXP-S, is currently being tested in clinical trials in multiple countries around the world. The company was founded by Florian Krammer, Peter Palese, Adolfo García-Sastre. | Director/Board Member | - |
Anciens postes connus de Dennis Charney
| Sociétés | Poste | Fin |
|---|---|---|
| GENEDX HOLDINGS CORP. | Director/Board Member | 14/06/2023 |
| Yale University | Corporate Officer/Principal | 01/01/2000 |
| National Institute of Mental Health | Corporate Officer/Principal | - |
Formation de Dennis Charney
| Rutgers State University of New Jersey | Undergraduate Degree |
| Pennsylvania State University College of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENEDX HOLDINGS CORP. | Health Services |
| Entreprise privées | 6 |
|---|---|
| National Institute of Mental Health | Government |
| AMDeC Foundation, Inc. | |
New York Genome Center
New York Genome Center Miscellaneous Commercial ServicesCommercial Services New York Genome Center operates as an independent, nonprofit academic research institution that provides genomic research. It provides research on neurodegenerative disease, neuropsychiatric disease, and cancer. The company was founded in 2011 and is headquartered in New York, NY. | Commercial Services |
Mount Sinai Genomics, Inc.
Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT. | Health Services |
CastleVax, Inc.
CastleVax, Inc. BiotechnologyHealth Technology CastleVax, Inc. is an American vaccine platform company based on technology developed at the Icahn School of Medicine at Mount Sinai, headquartered in an undisclosed location. The private company's platform uses a disease virus to induce the human immune system to produce neutralizing antibodies targeted at a range of emerging and pandemic viruses, including SARS-CoV-2. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax's leading candidate, NDV-HXP-S, is currently being tested in clinical trials in multiple countries around the world. The company was founded by Florian Krammer, Peter Palese, Adolfo García-Sastre. | Health Technology |
The Mount Sinai Health System, Inc.
The Mount Sinai Health System, Inc. Medical/Nursing ServicesHealth Services The Mount Sinai Health System, Inc. provides health care system services. It is an integrated health care system providing exceptional medical care to our local and global communities. The company is headquartered in New York, NY. | Health Services |
